Colonial River Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Colonial River Investments’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$277K	Sell	445 -58	-12%	-$39.5K	0.08%	209
2026 Q1	$389K	Buy	503 +11	+2%	+$8.42K	0.14%	151
2025 Q4	$380K	Buy	492 +8	+2%	+$5.43K	0.14%	162
2025 Q3	$272K	Buy	484 +36	+8%	+$20.4K	0.1%	189
2025 Q2	$251K	Buy	+448	New	+$250K	0.11%	185
2023 Q2	–	Sell	-329	Closed	-$270K	–	203
2023 Q1	$270K	Sell	329 -12	-4%	-$9.05K	0.16%	149
2022 Q4	$246K	Buy	341 +15	+5%	+$11.1K	0.16%	156
2022 Q3	$225K	Buy	+326	New	+$205K	0.16%	151

Other funds holding REGN

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Colonial River Investments's REGN Position: Q2 2026 in Review

Colonial River Investments reduced its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, selling an estimated $39.5K and leaving 445 shares worth $277K. The position accounts for 0.08% of the portfolio, ranked #209.

Colonial River Investments first reported a position in REGN in Q3 2022 and has held it in 8 quarters since. The position peaked at $389K in Q1 2026. 690 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Colonial River Investments held 445 shares of Regeneron Pharmaceuticals worth $277K as of Q2 2026.
Colonial River Investments sold 58 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $39.5K.
Regeneron Pharmaceuticals made up 0.08% of Colonial River Investments's portfolio in Q2 2026, its #209 holding.
Colonial River Investments first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 8 quarters since.
Colonial River Investments's Regeneron Pharmaceuticals position peaked at $389K in Q1 2026.
690 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Colonial River Investments's 13F filing for Q2 2026, filed 24 Jul 2026.